论文部分内容阅读
我们联合应用酚妥拉明与巯甲丙脯酸(CPT)对42例流行性出血热(EHF)急性肾衰患者进行治疗观察,获满意疗效。现报告如下。临床资料一般资料102例均系少尿期患者。按1986年全国EHF防治方案确诊和分型,并经间接免疫荧光抗体检查证实。治疗组42例,男30例;女12例;年龄17～64岁,平均42.1岁;急性肾衰发生日平均6.12天;重型20例,危重型22例,对照组60例,男43例,女17例;年龄19～68岁,平均40.4岁;急性肾衰发生病日平均6.22天;重型31例,危重型29例。两组资料无显著性差异。
We combined the application of phentolamine and captopril (CPT) in 42 cases of epidemic hemorrhagic fever (EHF) acute renal failure patients were observed and treated with satisfactory results. The report is as follows. 102 cases of clinical data are average oliguria patients. According to the 1986 national EHF prevention and treatment programs confirmed and sub-type, and confirmed by indirect immunofluorescence antibody test. The treatment group of 42 patients, 30 males and 12 females; aged 17 to 64 years, mean 42.1 years; the average incidence of acute renal failure 6.12 days; 20 cases of severe, critical type 22 cases, control group 60 cases, 43 males, Female 17 cases; aged 19 to 68 years, mean 40.4 years; acute renal failure average 6.22 days; 31 cases of heavy, 29 cases of critical type. No significant difference between the two groups of data.